{"id":"W1989740966","doi":"10.1111/j.1365-2141.2008.07573.x","title":"Reversibility of symptomatic peripheral neuropathy with bortezomib in the phase III APEX trial in relapsed multiple myeloma: impact of a dose‐modification guideline","year":2009,"lang":"en","type":"article","venue":"British Journal of Haematology","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":308,"is_retracted":false,"has_abstract":true,"ca_institutions":"Princess Margaret Cancer Centre","funders":"Takeda Oncology","keywords":"Medicine; Bortezomib; Peripheral neuropathy; Multiple myeloma; Internal medicine; Guideline; Surgery; Gastroenterology; Oncology; Diabetes mellitus; Pathology; Endocrinology","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.006722196,0.0003365013,0.001869348,0.0001515226,0.0002362867,0.0009830212,0.0006032199,0.0007227062,0.0007475943],"category_scores_gemma":[0.00360863,0.0001878259,0.00132858,0.0003318451,0.0003753704,0.0004561259,0.0002684777,0.002027888,0.0001190942],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.000562475,"about_ca_system_score_gemma":0.0009511712,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0004095241,"about_ca_topic_score_gemma":0.001805808,"domain_scores_codex":[0.9969333,0.002216564,0.000253816,0.0001365728,0.0003195191,0.0001401375],"domain_scores_gemma":[0.9972441,0.0010789,0.0009509159,0.0001998057,0.0001366306,0.0003896409],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"observational","study_design_scores_codex":[0.7252375,0.007624903,0.02477762,0.001336415,0.003344105,0.0001302973,0.0002619009,0.00434345,0.01204164,0.0004379044,0.003413042,0.2170512],"study_design_scores_gemma":[0.4999456,0.331193,0.1470447,0.0005429143,0.003207915,0.0004135968,0.0001357366,0.005087415,0.005574717,0.0007989214,0.005965577,0.00008990013],"study_design_candidate":"observational","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9864414,0.009042564,0.0003115914,0.000711764,0.0001031591,0.0006581348,0.0002775801,0.00003825404,0.002415599],"genre_scores_gemma":[0.9952863,0.001981466,0.0007915719,0.0007051866,0.0001146729,0.0004252321,0.0003257708,0.00001254069,0.0003572734],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.006722196,"threshold_uncertainty_score":0.03555077,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.03042436538693536,"score_gpt":0.361632983993509,"score_spread":0.3312086186065736,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}